Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 10, Goldman Sachs resumed coverage of the stock with a ‘Buy’ rating and a $19 ...

The funding round is likely to value the Bengaluru and San Francisco, California-based firm between $750 million and $800 ...

The number of AI-related jobs has grown in recent years, as more postings for AI engineers, GenAI consultants and other roles ...

The AI room really has some strong legs as we march through the peak of the summer season. And while investors should always ...

The Goldman Sachs Group, Inc. (NYSE:GS) is one of the stocks Jim Cramer reflected on. Cramer noted that the firm “may have ...

Despite dire forecasts and corporate hype, artificial intelligence (AI) has yet to deliver the sweeping job losses many ...

In addition to the new funding, which saw participation from Japanese law firm Mori Hamada, the contract review and matter ...

Goldman Sachs posted strong Q2 results, raised dividends 33%, and sees AI-driven growth ahead, despite valuation risks after ...

Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Cognition is seeking to achieve a jaw-dropping $10B valuation as investors race to back the next big thing. Can its ...

Goldman Sachs is revolutionising its workforce by deploying Devin, an AI software engineer developed by London-based start-up Cognition, reported The Times ...